Etiology and Microbial Pathogenesis of Acute and Late Onset Vascular Graft Infections

  • Charles E. EdmistonJr.
  • David D. Schmitt
  • Gary R. Seabrook


Infection of prosthetic vascular grafts presents as a significant complication of peripheral arterial reconstruction with high morbidity and mortality. Acute graft infection is often associated with Staphylococcus aureus or Pseudomonas aeruginosa contamination and presents within days to weeks of revascularization. Late onset infections typically present months to years post-implantation. Staphylococcus epidermidis is the predominant isolate found in these late occurring infections and slime-positive strains are often recovered from culture. Multiple factors potentiate these late infections and complicate management.


Graft Material Vascular Graft Graft Infection Prosthetic Graft Microbial Adherence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Archer GL, Tenenbaum MJ: Antibiotic resistance to Staphylococcus epidermidis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 17: 26972, 1980.Google Scholar
  2. 2.
    Bandyk DF: Vascular graft infection: Epidemiology, bacteriology, and pathogenesis. In Bernard VM, Towne JB (Eds), Complications in vascular surgery, 2nd edition. Crune 0026 Stratton, Inc, Orlando, FL. pp 471 – 85, 1985.Google Scholar
  3. 3.
    Bandyk DF, Berni GA, Thiele BL, Towne JB:Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg 119: 102 – 8, 1984.CrossRefGoogle Scholar
  4. 4.
    Bayston R: A m odel of catheter colonization in vitro and its relationship to clinical catheter infections. J Infect 9: 271 – 6, 1984.CrossRefGoogle Scholar
  5. 5.
    Bayston R: Hydrocephalus shunt infection and their treatment. J Antimicro Chemo 15: 259 – 61, 1985.CrossRefGoogle Scholar
  6. 6.
    Bayston R, Penny SR: Excessive production of mucoid substance in Staphylococcus SIIA: A possible factor in colonization of Holter shunts. Dev Med Child Neurol 27 (suppl): 25 – 28, 1972.Google Scholar
  7. 7.
    Brook I: Role of anaerobic bacteria in aortofemoral graft infection. Surgery 104: 843 – 845, 1983.Google Scholar
  8. 8.
    Bunt TJ: Synthetic vascular graft infections. I. Graft infections. Surgery 93: 733 – 46, 1983.Google Scholar
  9. 9.
    Conn JF, Hardy JD, Chavez CM, Fain WR: Infected arterial grafts. Ann Surg 171: 704 – 12, 1970.CrossRefGoogle Scholar
  10. 10.
    Dougherty SU, Simmons RL: Infections in bionic man. Curr Prob Surg 19: 218 – 319, 1982.Google Scholar
  11. 11.
    Edmiston CE, Schmitt DD, Seabrook GR: Coagulase negative staphylococcal infections in vascular surgery: Epidemiology and pathogenesis. Infect Control Hosp Epidemiol 10: 111 – 17, 1988.CrossRefGoogle Scholar
  12. 12.
    Fry WJ, Lindenauer SM: Infection complicating the use of plastic arterial implants. Arch Surg 94: 600 – 09, 1967.CrossRefGoogle Scholar
  13. 13.
    Goldstone J, Moore WS: Infection in vascular prosthesis. Am J Surg 128: 225 – 233, 1974.CrossRefGoogle Scholar
  14. 14.
    Greco RS, Trooskin SZ, Donetz AP, Harvey RA: The application of antibiotic bonding to the treatment of established vascular prosthetic infection. Arch Surg 120: 71 – 5, 1985.CrossRefGoogle Scholar
  15. 15.
    Hoffert PW, Gensler S, Haimovici H: Infection complications of arterial grafts. Personal experience with 12 cases and review of the literature. Arch Surg 90: 427 – 35, 1965.CrossRefGoogle Scholar
  16. 16.
    Hogt AH, Dankert J, DeVries JA, Feijen J: Adhesion of coagulase-negative staphylococci to biomaterials. J Gen Microbio1129: 2959 – 68, 1983.Google Scholar
  17. 17.
    Javid H, Julian OC, Dye WS: Complications of abdominal aortic grafts. Arch Surg 85: 142 – 53, 1962.CrossRefGoogle Scholar
  18. 18.
    Kaebnick HW, Bandyk DF, Bergamini TM, Towne JO: The microbiology of explanted vascular prostheses. Surgery 102: 756 – 62, 1987.Google Scholar
  19. 19.
    Kaiser AB, Clayson KR, Mulherin JL, Roach AC, Allen TR, Edwards WH, Dale WA: Antibiotic prophylaxis in vascular surgery. Ann Surg 188: 283 – 89, 1978.CrossRefGoogle Scholar
  20. 20.
    Kloos WE, Musselwhite MS: Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 330: 381 – 95, 1975.Google Scholar
  21. 21.
    Levy MF, Schmitt DD, Edmiston CE Bandyk, DF, Krepel CJ, Seabrook GR, Towne JB: Sequential analysis of staphylococcal colonization by body surface cultures on patients undergoing vascular surgery. Proc 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Pg. 285, October 22, 1988.Google Scholar
  22. 22.
    Liekweg WG Jr., Greenfield LF: Vascular prosthetic infection: Collected experience and results of treatment. Surgery 81: 335 – 42, 1977.Google Scholar
  23. 23.
    Lorentzen JE, Nielsen OM, Arendrup H, Kimose HH, Bille S, Andersen J, Jensen CH, Jacobsen F, Roder OC: Vascular graft infection: An analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 98: 81 – 6, 1985.Google Scholar
  24. 24.
    Marrie TJ, Costerton JW: Morphology of bacterial attachment of cardiac pacemaker leads and power packs. J Clin Microbiol 19: 687 – 93, 1984.Google Scholar
  25. 25.
    Moore WS, Malone JB: Vascular infection. In Howard RJ, Simmons RL (Eds) Surgical Infectious Disease. Appleton 0026 Lange, Norwalk, CT, 1988, pp 585 – 604.Google Scholar
  26. 26.
    Pitt HA, Postier RG, MacGowan WL, Frank LW, Surmak AJ, Sitzman JV, Bouchier-Hayes D: Prophylactic antibiotics in vascular surgery - Topical, systemic or both? Ann Surg 192: 356 – 64, 1980.CrossRefGoogle Scholar
  27. 27.
    Rubin JR, Malone JB, Goldstone J: The role of the lymphatic system in acute arterial prosthetic graft infection. J Vasc Surg 2: 92 - 8, 1985.Google Scholar
  28. 28.
    Seabrook GR, Schmitt DD, Bandyk DF, Edmiston CE, Krepel CJ, Towne JB: Anastomotic femoral pseudoaneurysm: A prospective investigation of occult infection as an etiologic factor. Presented at Midwestern Vascular Surgical Society, Chicago, IL, September 29, 1989.Google Scholar
  29. 29.
    Schmitt DD, Bandyk DF, Edmiston CE, Levy MF, Seabrook GR, Towne JB: The in vitro effect of subinhibitory quinolones and vancomycin levels on adherence of slime producing Staphylococcus epidermidis to vascular prostheses. Rev Infect Dis 11: S947 – S948, 1989.CrossRefGoogle Scholar
  30. 30.
    Schmitt DD, Bandyk DF, Pequet AJ, Towne JB: Bacterial adherence to vascular prostheses. J Vasc Surg 3: 732 – 40, 1986.Google Scholar
  31. 31.
    Schmitt DD, Bandyk DF, Pequet AJ, Malangoni MA, Towne JB: Mucin production by Staphylococcus epidermidis. Arch Surg 121: 89 – 95, 1986.CrossRefGoogle Scholar
  32. 32.
    Schmitt DD, Krepel CJ, Edmiston CE, Seabrook GR, Bandyk DF, Towne JB: Impact of post-antibiotic effect (PAE) of bacterial adherence to vascular prostheses. Abstract presented at Association for Academic Surgery, Louisville, KY, November 13, 1989.Google Scholar
  33. 33.
    Schmitt DD, Levy MF,Bandyk DF, Krepel CJ, Edmiston CE, Seabrook GR, Towne JB: The effect of subinhibitory concentrations of antibiotics on adherence of slime producing Staphylococcus epidermidis to prosthetic surfaces. Chemotherapia. In Press.Google Scholar
  34. 34.
    Schoenbaum SC, Gardner P, Shillito J: Infection of cerebrospinal fluid shunts. Epidemiology, clinical manifestation, and therapy. J Infect Dis 131: 543 – 51, 1975.CrossRefGoogle Scholar
  35. 35.
    Shah PM, Modak S, Fox CL, Babu SC, Sampath L, Clauss RH, Stahl WM: PTFE graft treated with silver norfioxacin (AgNF): Drug retention and resistance to bacterial challenge. J Surg Res 42: 298 – 303, 1987.CrossRefGoogle Scholar
  36. 36.
    Shaw RS, Baue AE: Management of sepsis complicating arterial reconstructive surgery. Surgery 53: 75 – 86, 1963.Google Scholar
  37. 37.
    Sheth NK, Franson TR, Sohnle PG: Influence of bacterial adherence to intravascular catheters on in vitro antibiotic susceptibility. Lancet 1: 1266 – 1268, 1985.CrossRefGoogle Scholar
  38. 38.
    Slaughter L, Morris JE, Starr A: Prosthetic valvular endocarditis: A 12 year review. Circulation 47: 1319 – 25, 1973.Google Scholar
  39. 39.
    Szilagyi DE, Smith DF, Elliot JP, Vrandecic MP: Infection in arterial reconstructions with synthetic grafts. Ann Surg 176: 321 – 33, 1972.CrossRefGoogle Scholar
  40. 40.
    Tollefson DF, Bandyk DF, Kaebnick HW, Seabrook GR, Towne JB: Surface biofilm disruption. Arch Surg 122: 38 – 43, 1987.CrossRefGoogle Scholar
  41. 41.
    Vetsch R, Bandyk DF, Schmitt DD, Bergamini TM, Storey JD, Towne JB: Anastomotic tensile strength follow-ing in situ replacement of an infected abdominal aortic graft. Arch Surg 124: 425 – 8, 1989.CrossRefGoogle Scholar
  42. 42.
    Voorhees AB, Jaretski A, Blakemore AH: Use of tubes constructed of Vingon-N cloth in bridging arterial defects. Ann Surg 135: 332 – 8, 1952.CrossRefGoogle Scholar
  43. 43.
    Wesolowski SH, Fries CC, Karlson KE, DeBakey ME, Sawyer PN: Porosity: prime determinant of ultimate fate of synthetic grafts. Surgery 50: 91 – 6, 1961.Google Scholar

Copyright information

© Springer-Verlag London Limited 1990

Authors and Affiliations

  • Charles E. EdmistonJr.
  • David D. Schmitt
  • Gary R. Seabrook

There are no affiliations available

Personalised recommendations